Factive (Gemifloxacin)

Author , posted on July 5, 2017

Category:


Gemifloxacin (Generic)

Gemifloxacin Mesylate

Select Quantity:

Factive (Gemifloxacin) Dosage and Side Effects

FACTIVE is used to treat different types of bacterial infections in the lungs.

Proper Use of this medication

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Take FACTIVE at the same time each day with a full glass of water (8 ounces). Drink several extra glasses of fluid each day while you are taking FACTIVE. You may take FACTIVE with or without food.

Do not take FACTIVE with dairy products such as milk or yogurt, or with calcium-fortified juice. You may eat or drink these products as part of a regular meal, but do not use them alone when taking FACTIVE. They could make the medication less effective.

Take this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. FACTIVE will not treat a viral infection such as the common cold or flu.

Do not share this medicine with another person (especially a child), even if they have the same symptoms you have.

Store at room temperature away from moisture, heat, and light.

Seek emergency medical attention or call the Poison Help line.

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives, or the first sign of a skin rash; rapid heart rate, difficulty breathing; swelling of your face, lips, tongue, or throat.

FACTIVE may cause swelling or tearing of (rupture) a tendon. FACTIVE can also have serious effects on your nerves, and may cause permanent nerve damage. Stop taking this medicine and call your doctor at once if you have:

  • signs of tendon rupture--sudden pain, swelling, bruising, tenderness, stiffness, movement problems, or a snapping or popping sound in any of your joints (rest the joint until you receive medical care or instructions); or
  • nerve symptoms--numbness, tingling, burning pain, or being more sensitive to temperature, light touch, or the sense of your body position.

Stop using FACTIVE and call your doctor at once if you have:

  • headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
  • upper stomach pain, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • muscle weakness or trouble breathing;
  • diarrhea that is watery or bloody;
  • sudden weakness or ill feeling, fever, chills, sore throat, mouth sores, easy bruising or bleeding;
  • depression, confusion, hallucinations, paranoia, tremors, feeling restless or anxious, insomnia, nightmares, thoughts of hurting yourself;
  • seizure (convulsions); or
  • increased pressure inside the skull-- severe headaches, ringing in your ears, dizziness, nausea, vision problems, pain behind your eyes.

Common side effects may include:

  • nausea, vomiting, mild stomach pain, mild diarrhea;
  • mild dizziness; or
  • mild headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

 

Warnings and Precautions

You may not be able to use FACTIVE if you have a muscle disorder. Tell your doctor if you have a history of myasthenia gravis.

FACTIVE may cause swelling or tearing of a tendon (the fiber that connects bones to muscles in the body), especially in the Achilles' tendon of the heel. This effect may be more likely to occur if you are over 60, if you take steroid medication, or if you have had a kidney, heart, or lung transplant.

Stop taking FACTIVE and call your doctor at once if you have sudden pain, swelling, bruising, tenderness, stiffness, or movement problems in any of your joints. Rest the joint until you receive medical care or instructions.

You should not use this medication if you are allergic to FACTIVE or other fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin, norfloxacin, and others).

To make sure FACTIVE is safe for you, tell your doctor if you have:

  • slow heartbeats or other heart rhythm disorder, especially if you take medication to treat it;
  • a personal or family history of Long QT syndrome;
  • tendon problems, arthritis or other joint problems (especially in children);
  • a muscle or nerve disorder;
  • liver or kidney disease;
  • seizures or epilepsy;
  • a history of head injury or brain tumor;
  • a history of allergic reaction to an antibiotic;
  • diabetes (especially if you use insulin or take oral diabetes medication);
  • low levels of magnesium or potassium in your blood; or
  • if you use a blood thinner (warfarin, Coumadin) and have "INR" or prothrombin time tests.

It is not known whether FACTIVE will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether FACTIVE passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Interactions with this medication

You may be taking certain other medicines that should not be taken at the same time as FACTIVE. Avoid taking the following medicines within 3 hours before or 2 hours after you take FACTIVE. These other medicines can make FACTIVE much less effective when taken at the same time:

  • antacids that contain magnesium or aluminum (such as Maalox, Mylanta, or Rolaids), or the ulcer medicine sucralfate (Carafate);
  • didanosine (Videx) powder or chewable tablets; or
  • vitamin or mineral supplements that contain iron or zinc.

Avoid exposure to sunlight or tanning beds. FACTIVE can make you sunburn more easily. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors. Call your doctor if you have severe burning, redness, itching, rash, or swelling after being in the sun.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, stop taking FACTIVE and call your doctor. Do not use anti-diarrhea medicine unless your doctor tells you to.

FACTIVE may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Tell your doctor about all medicines you use, and those you start or stop using during your treatment with FACTIVE, especially:

  • probenecid;
  • a diuretic or "water pill";
  • heart rhythm medication--amiodarone, disopyramide, dofetilide, dronedarone, procainamide, quinidine, sotalol, and others;
  • medicine to treat depression or mental illness--amitriptylline, clomipramine, desipramine, iloperidone, imipramine, nortriptyline, ziprasidone, and others; or
  • NSAIDs (nonsteroidal anti-inflammatory drugs)--aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib, diclofenac, indomethacin, meloxicam, and others.

This list is not complete. Other drugs may interact with FACTIVE, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Other related products

Other related products

Menopur (Menotropins)

Author , posted on July 5, 2017

Category:


Menopur

Menotropins (Fsh;Lh)

Select Quantity:

Menopur (Menotropins) Dosage and Side Effects

Menopur is used in IVF (in-vitro fertilization or “test tube”) procedures or other assisted conception techniques to induce multiple follicular development.

Proper Use of this medication

MENOPUR must be taken by injection.

Every treatment is individualized. Yours has been carefully designed for you by your doctor according to your own specific needs. It is very important that you keep your appointments and follow your doctor's instructions, particularly with regard to the amount and frequency of the medication you are taking. If you have concerns regarding your dosage, consult your doctor. Do not adjust your dosage without being instructed to do so. If you forget or miss an injection, do not panic, but you should call your doctor for advice.

The dose is chosen by your doctor. Women participating in assisted reproduction programs are usually started on a dose of 225 IU MENOPUR. Based on clinical monitoring including ovarian ultrasound scans, and blood and urine tests, you doctor may adjust the dose once every two days. The maximum daily dose of MENOPUR is 450 IU daily.

Instructions for Reconstitution and Subcutaneous Administration:

(See package insert for illustrations).

Your doctor has prescribed MENOPUR for subcutaneous injection. This means that it is injected through a short injection needle into the tissue just under your skin. This instruction sheet will help you prepare and inject your medication at home. Please review it completely prior to starting the procedure. Do not attempt this procedure if you are unsure of how to prepare or administer the injection. If you have any questions, call your doctor or nurse.

  1. Before You Start
    • Wash your hands with antibacterial soap and use alcohol to clean the area you will be working on.
    • Have these supplies ready:
      1. Vial (or vials) of MENOPUR, 75 IU
      2. A vial of Sodium Chloride 0.9% (sterile diluent) that is conveniently packaged with MENOPUR
      3. A syringe and sterile needles (check with your doctor about which syringe and needle size to use)
      4. Alcohol pads and rubbing alcohol
      5. Gauze and cotton balls
      6. A needle disposal container
  2. Preparing your medicine and filling the syringe
  3. Remember: Only the Sodium Chloride (sterile diluent) provided must be used to reconstitute MENOPUR.
    • Remove syringe and larger needle from the wrapper. While holding the protective cap, twist needle clockwise to make sure needle is secure. Set syringe and needle aside.
    • Remove plastic caps from tops of vials of MENOPUR and sterile diluent.
    • Wipe tops of vials with alcohol to sterilize them. Don't touch tops of vials once you have sterilized them.
    • Uncap needle by carefully twisting needle cap clockwise and pulling cap upward. Avoid twisting needle counterclockwise, as this can cause needle to separate from syringe.
    • Insert needle through rubber stopper of sterile diluent vials.
    • Tip sterile diluent vial and, with needle in fluid, pull back on plunger to withdraw fluid into syringe up to the amount instructed by your doctor.
    • Withdraw needle from sterile diluent vial. Slowly inject sterile diluent into vial containing MENOPUR powder, aiming sterile diluent at side of vial to avoid creating bubbles. The solution should be clear and colourless.
    • The MENOPUR powder will dissolve quickly. Do not shake vial because this will create bubbles.
    • FOR PATIENTS REQUIRING A SINGLE INJECTION FROM MULTIPLE VIALS OF MENOPUR, UP TO 6 VIALS CAN BE RECONSTITUTED WITH 1 ML OF STERILE SALINE FOR INJECTION, USP.
    • This can be accomplished by reconstituting a single vial as described above (see step 2). Then draw the entire contents of the first vial into a syringe, and inject the contents into a second vial of lyophilized MENOPUR. Gently swirl the second vial as described above, once again checking to make sure the solution is clear and free of particles. This step can be repeated with 4 additional vials for a total of up to 6 vials of lyophilized MENOPUR into 1 mL of diluent.
    • As soon as powder has completely dissolved, withdraw all MENOPUR solution into syringe. There are two ways of doing this:
      1. Leave vial on counter, tilt it, pull back on plunger to withdraw all solution, OR
      2. Turn vial upside down, pull back on plunger to withdraw solution as you slowly lower needle.
  4. Changing the Needle
    • While holding syringe upward, replace needle cap and remove large needle by twisting it counterclockwise. Replace with the small, subcutaneous needle by twisting it clockwise onto syringe.
    • Hold syringe straight up. Draw back slightly on plunger and tap syringe so that any air bubbles rise to top. Slowly press plunger until all air is out of syringe and small drop of solution forms at tip of needle.
    • Tap the syringe to remove the drop of solution at the tip of the needle.
    • Carefully recap needle to keep it sterile.
    • MENOPUR solution is now ready for injection.
  5. If an uncapped needle EVER comes into contact with anything except MENOPUR or sterile diluent, do not inject yourself with it. Immediately remove needle and replace it with a new sterile needle.
  6. Injecting the Medicine
  7. MENOPUR should be injected into a skin fold on your abdomen a few inches below your navel, to the left or right.
  8. Each day, use the alternate side of your abdomen to help prevent soreness.
    • Carefully clean injection site area with an alcohol pad and allow site to air-dry.
    • Remove needle cap from syringe.
    • Hold syringe in one hand. Use your other hand to gently grasp a fold of skin in the injection site area between your thumb and index finger.
    • Hold syringe perpendicular (at right angle) to skin like a dart and quickly insert needle all the way into skin fold.
    • Depress plunger of syringe with a steady motion until all fluid is injected beneath skin.
    • Release skin fold and pull needle straight out. Recap needle and discard syringe and needle into a disposal container. If any bleeding should occur, simply place a small piece of gauze or cotton over the injection site and apply gentle pressure to stop bleeding.
    • If injection site becomes sore, application of ice for brief intervals may help relieve any discomfort.
  9. Dispose of the Syringe and Needles
  10. Safely dispose of all used syringes and needles in a needle disposal container with a lid. Extra sterile diluent should be thrown away. After you finish your course of treatment, ask your healthcare provider how to properly dispose of the needle disposal container.

Side Effects

Fertility drugs are safe to take with close monitoring by your doctor. As with all medications, there is a potential for side effects. Some patients undergoing gonadotropin therapy may experience breast tenderness, bloating, flushing, vomiting, nausea and diarrhea. They are temporary and will resolve once treatment is stopped. Other adverse reactions may include allergic sensitivity such as a rash or local swelling at the injection site.

The greatest concern your doctor will have is Ovarian Hyperstimulation Syndrome (OHSS). To avoid the development of OHSS, your doctor will carefully monitor your response to MENOPUR. Ovarian enlargement, sometimes accompanied by abdominal bloating and pain, may occur in about 20% of women taking gonadotropins. This is generally reversed with cessation of treatment and severe life-threatening cases are rare.

A causal relationship between treatment of fertility drugs and ovarian cancer has not been established.

If you experience any unusual symptoms or side effects, you should report them to your doctor immediately. It is also wise to discuss the possibility of side effects with your doctor before your treatment.

Warnings and Precautions

Will MENOPUR put me at risk for reproductive complications?

Treatment with gonadotropin preparations may lead to unwanted overstimulation of the ovaries known as Ovarian Hyperstimulation Syndrome (OHSS). The first symptoms of ovarian stimulation may be noticed as pain in the abdomen, feeling sick or diarrhea. More severe cases may have accumulation of fluid in the abdomen and/or chest, weight gain and the occurrence of blood clots. Contact your doctor without delay if you experience any of these symptoms during treatment or within a few days after the last injection.

The incidence of multiple births with MENOPUR is no different from any other gonadotropin and is dependent upon the protocol used by the clinic. Your doctor will monitor you closely to help minimize the possibility of multiple gestations. The majority of births—about 85% are single babies. Of those women who have multiple births, the majority of these are twins. Only few women conceive 3 or more babies. Even so, neither single nor multiple births can be totally guaranteed.

Since women with infertility undergoing infertility assisted reproduction, and particularly IVF, often have tubal abnormalities, the incidence of ectopic pregnancies may be increased. Early ultrasound confirmation of pregnancy in the uterus is therefore of importance.

Interactions with this medication

There have been no drug interactions reported with this medication.

Other related products

Ezetrol (Ezetimibe)

Author , posted on July 5, 2017

Category:


Ezetrol (Ezetimibe) Dosage and Side Effects

EZETROL helps to reduce the amount of cholesterol and triglycerides in your blood.

Proper Use of this medication

Usual dose:

  • EZETROL should be taken as directed. Take one 10mg tablet by mouth each day, preferably at the same time of day. EZETROL can be taken with or without food.
  • Continue taking your other cholesterol-lowering medicines known as statins or fenofibrate unless your doctor tells you to stop.
  • If you are taking a statin or fenofibrate, EZETROL can be taken at the same time.
  • Even if you are taking medication to treat high cholesterol, it is important to have your cholesterol measured regularly. You should also know your cholesterol levels and goals.

Overdose:

Take EZETROL only as prescribed for you. If you take more EZETROL than you were prescribed, contact your doctor or pharmacist.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed dose:

If you miss a dose, just resume the usual schedule of one tablet daily.

Side Effects

EZETROL is generally well tolerated.

  • When used alone, the following common side effects have been reported: abdominal pain; diarrhea; flatulence; tiredness; viral infection; throat infection (pharyngitis); nose infection (sinusitis); joint pain (arthralgia); back pain; and coughing.

The following uncommon side effects have been reported: elevations in some laboratory blood tests of liver (transaminases) or muscle (CK) function; indigestion; heartburn; nausea; muscle spasms; neck pain; decreased appetite; hot flush; high blood pressure; chest pain and pain.

  • When used with a statin, the following common side effects have been reported: headache; tiredness; abdominal pain; diarrhea; joint pain (arthralgia); muscle pain (myalgia); back pain; throat infection (pharyngitis); nose infection (sinusitis); upper chest infection (respiratory tract); and changes in certain laboratory blood tests.

The following uncommon side effects have been reported: tingling sensation; dry mouth; gastritis; itching; rash; hives; muscular weakness; pain in arms and legs; unusual tiredness or weakness; and swelling, especially in the hands and feet.

When used with fenofibrate, the following side effect was reported: abdominal pain.

  • In general use, the following side effects have been reported: raised red rash, sometimes with target-shaped lesions; dizziness; depression; tingling sensation; constipation; and unusual tiredness or weakness.
  • You should contact your doctor if you develop persistent and severe muscle aches or pains with no obvious explanation at any time after starting to take EZETROL.

If you are prescribed EZETROL with a statin, your doctor will order routine blood tests to check your liver function before and after starting treatment.

Talk to your doctor anytime you have a medical problem you think may be related to EZETROL.

Warnings and Precautions

Serious Warnings and Precautions

  • Liver disease (Hepatitis)
  • Pancreas disease (Pancreatitis)
  • Muscle pain (Myopathy/Rhabdomyolysis, myalgia)
  • Severe allergic reaction (Anaphylaxis)

Before you use EZETROL talk to your doctor if you:

  • are pregnant, plan to become pregnant or think you might be pregnant.
  • are breast-feeding. EZETROL may be passed in your milk to your baby.
  • have now or have had in the past any medical problems (including liver disease or liver problems).

Interactions with this medication

You should always tell your doctor about all drugs that you are taking or plan to take as well as those obtained without a prescription.

Drugs that may interact with EZETROL include:

  • Cyclosporine
  • Cholestyramine (a resine/bile acid sequestrant) or any other bile acid sequestrant. In that case, EZETROL should be taken at least 2 hours before or 4 hours after taking the bile acid sequestrant.
  • Fibrates

Other related products

Other related products

Exjade (Deferasirox)

Author , posted on July 5, 2017

Category:


Exjade

Deferasirox

Select Quantity:
Select Quantity:
Select Quantity:

Deferasirox (Generic)

Deferasirox

Select Quantity:
Select Quantity:
Select Quantity:

Exjade (Deferasirox) Dosage and Side Effects

EXJADE binds to iron and removes it from the blood stream. EXJADE is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old. EXJADE is also used to treat chronic iron overload syndrome caused by a genetic blood disorder in adults and children who are at least 10 years old.

Proper Use of this medication

Always take EXJADE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

Usual dose:

For patients receiving regular blood transfusion:

  • Initial dose: 10 mg, or 20 mg, or 30 mg per kg body weight daily.

  • Maximum dose: 30 mg per kg body weight daily.

For patients with thalassemia syndromes who do not require regular blood transfusions:

  • Initial dose: 10 mg per body weight daily.

  • Maximum dose: 20 mg per kg body weight daily.

The daily dose will be adjusted depending on how you respond to the treatment.

When to take EXJADE:

  • Take EXJADE once a day, every day, at about the same time each day;

  • Must be taken on an empty stomach;

  • Then wait at least 30 minutes before eating the first meal of the day.

How to take EXJADE:

  • Drop the tablet(s) into a glass of water, orange or apple juice (100 mL for doses of less than 1 g, and 200 mL for doses of 1 g or more).

  • Stir until the tablet(s) dissolve completely. The liquid in the glass will look cloudy.

  • Drink everything in the glass. Then add a little water or juice to what is left in the glass and drink that too.

Do not dissolve the tablets in fizzy drinks or milk.

Do not chew, break or crush the tablets. Do not swallow the tablets whole.

Overdose:

If you have taken too much EXJADE, or if someone else accidentally takes your tablets, contact your doctor or go to the hospital or contact your local poison control centre. Show them the blister package of tablets. Medical treatment may be necessary.

Missed dose:

If you miss a dose, take it as soon as you remember on that day. Take your next dose as scheduled. Do not take a double dose on the next day to make up for the forgotten dose. Do not take more than one dose on the same day.

Side Effects

Like all medicines, EXJADE can cause side effects.

Some side effects are common.

These side effects may affect between 1 and 10 in every 100 patients.

  • Gastrointestinal disorders, such as nausea, vomiting, diarrhea, pain in the abdomen, bloating, constipation, indigestion

  • Severe rash/skin disorders

  • Headache

Other side effects are uncommon.

These side effects may affect less than 1 in every 100 patients.

  • Dizziness

  • Fever

  • Sore throat

  • Swelling of arms or legs

  • Change in the colour of the skin

  • Anxiety

  • Sleep disorder

  • Tiredness

  • Hearing loss

  • Vision change (early cataracts)

  • Ulcer and/or bleeding in the stomach or intestine

  • Liver disorders

  • Traces of blood and/or protein in the urine

  • Hair loss

You will have some blood tests while taking EXJADE. Your doctor will look for any changes in kidney function, liver function or in blood cell counts.

Your doctor may also want to test your eyesight and hearing while you are taking EXJADE.

For any unexpected effects while taking EXJADE contact your doctor or pharmacist.

Warnings and Precautions

Serious Warnings and Precautions

EXJADE should be prescribed by doctor experienced in the treatment of chronic iron overload due to blood transfusions.

EXJADE has not been studied in patients with severe kidney and liver problems (impairment).

Serious adverse events with the use of EXJADE include:

  • acute kidney failure

  • liver failure

  • ulcer or bleeding in the stomach or intestines

BEFORE you use EXJADE talk to your doctor or pharmacist if you have:

  • severe heart problems (acute cardiac failure)

  • ulcer or bleeding in the stomach or intestines

  • liver or kidney problems

  • severe intolerance to lactose (milk sugars). EXJADE tablets contain lactose

  • visual (eye) problems

  • hearing problems

  • blood disorders (a low level of platelets or white blood cell count)

  • skin problem.

During treatment with EXJADE, talk to your doctor or pharmacist immediately if you have:

  • Rash, skin reddening, pain, swelling or blistering of lips, eyes or mouth, skin peeling and flu-like symptoms. If you get these symptoms, your doctor may stop your treatment.

Older people (age 65 years and over):

Elderly patients may experience more side effects than younger patients. They should be monitored closely by their doctor for side effects that may require a dose adjustment.

Children and adolescents (age 2 years to 16 years):

Their growth and development need to be monitored during treatment with EXJADE.

Pregnancy and breast-feeding:

EXJADE is not recommended during pregnancy unless clearly necessary. If you are pregnant or think that you may be, tell your doctor. EXJADE may decrease the effect of hormonal contraceptives, and you may be at risk of getting pregnant if you are taking a hormonal contraceptive.

Breast-feeding is not recommended during treatment with EXJADE.

Driving and using machines:

If you feel dizzy after taking EXJADE, do not drive or operate any tools or machines until you are feeling normal again.

You should receive regular blood and urine tests before and during treatment with EXJADE. You may also be assessed by Magnetic Resonance Imaging (MRI). These will monitor the amount of iron in your body (level of ferritin) to see how well EXJADE is working. The tests will also monitor your kidney function (blood level of creatinine, presence of protein in the urine) and liver function (blood level of transaminases, bilirubin and alkaline phosphatase). Your doctor will take these tests into consideration when deciding on the dose of EXJADE most suitable for you and will also use these tests to decide when you should stop taking EXJADE.

Your eyesight and hearing will also be tested before and periodically during treatment as a precautionary measure.

Interactions with this medication

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including non-prescription drugs (obtained without a prescription), vitamins and natural products. Some medicines may interact with EXJADE.

  • Antacids (medicines used to treat heartburn) containing aluminum should not be taken at the same time of day as EXJADE.

  • Other iron chelating agents should not be taken while on treatment with EXJADE, as the safety and efficacy of a combination with EXJADE has not been established.

In particular tell your doctor if you are taking any of the following:

  • cyclosporine (used in transplantation to prevent graft rejection or for any other condition)

  • simvastatin (used to lower cholesterol)

  • hormonal contraceptive agents (birth control medicines)

  • certain painkillers or anti-inflammatory medicines (e.g. acetylsalicylic acid, ibuprofen, corticosteroids)

  • oral bisphosphonates (used to treat osteoporosis)

  • anticoagulant medicines (used to prevent or treat blood clotting)

  • repaglinide (used to treat diabetes)

  • rifampicin (used to treat tuberculosis)

  • paclitaxel (used in cancer treatment)

  • phenytoin, phenobarbital (used to treat epilepsy)

  • ritonavir (used in the treatment of HIV infection)

  • cholestyramine (used mainly to lower cholesterol)

  • theophylline (used to treat respiratory diseases such as asthma)

Other related products

Requip XL (Ropinirole)

Author , posted on July 5, 2017

Category:


Requip XL

Ropinirole Hydrochloride

Select Quantity:
Select Quantity:
Select Quantity:

Requip XL

Ropinirole Hydrochloride

Select Quantity:
Select Quantity:
Select Quantity:

Ropinirole XL (Generic)

Ropinirole Hydrochloride

Select Quantity:
Select Quantity:
Select Quantity:

Requip XL (Ropinirole) Medication Information

Uses

Requip is a dopamine agonist that is used to treat Parkinson’s disease. 

Dosage

The tablets are available in several different strengths:

  • 2 mg
  • 4 mg
  • 6 mg
  • 8 mg
  • 12 mg

Side Effects

The most common side effects of Requip include:

  • Nausea
  • Somnolence
  • Hypertension 
  • Headache 
  • Abdominal pain
  • Dizziness
  • Constipation 

Speak with your doctor for a full list of side effects that apply to you if you are taking Requip.

Precautions

Requip can cause drowsiness, and sudden sleepiness, which can be dangerous if patients are operating heavy machinery. 

Requip can cause a change in blood pressure and heart rate, so it is important to monitor these in patients. 

This medication can cause problems with impulse control and make patients more compulsive. 

Interactions

The most common drug interactions with Requip include:

  • Estrogen
  • Phenothiazines
  • Butyrophenones
  • Thioxanthenes
  • Metoclopramide

Speak with your doctor for more information and before starting a new medication with Requip. 

Storage

Store at room temperature (77ºF). Requip should be dispensed in a tight and light-resistant container. 

Pharmacist Tips

  • Requip needs to be taken as it is prescribed by your doctor. 
  • Requip can be taken with or without food, but it needs to be swallowed whole. 
  • Requip contains ropinirole, this medication is also available as an immediate release tablet.  

Ropinirole FAQs

Can Requip keep you awake?

Requip usually makes patients drowsy. 

 

How long does Requip last?

Requip can stay in the body up to 30 hours. 

 

Can you stop Requip abruptly?

Patients can experience withdrawal if they stop this medication quickly. 

 

Is Requip a muscle relaxant?

No, Requip is not a muscle relaxant, it work on the dopamine receptor in the brain. 

 

Does Requip help with anxiety?

Requip has been shown to help with anxiety and depression symptoms. 

 

Related Drugs

Reference:

Requip {package insert}. Research Triangle Park, NC: GlaxoSmithKline; 2017.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022008s009lbl.pdf

PharmD Medical Writer

Author: Dr. Larisa Roybal, PharmD

Dr. Roybal is a board-certified pharmacotherapy specialist who has practiced in both ambulatory and acute care settings. Her pharmacy interests include oncology and general inpatient pharmacy.

Ortho Evra Patches (Ethinyl Estradiol/ Norelgestromin)

Author , posted on July 5, 2017

Category:


Evra Patches

Ethinyl Estradiol, Norelgestromin

Select Quantity:

Evra Patches

Ethinyl Estradiol, Norelgestromin

Select Quantity:

Evra Patches (Ethinyl Estradiol, Norelgestromin) Dosage and Side Effects

EVRA is used for prevention of pregnancy.

Proper Use of this medication

If your patch becomes loose, lifts at the edges or falls off:

  • for less than one day, try to re-apply it or apply a new patch immediately. No back-up contraception is needed. Your “Patch Change Day” will remain the same.
  • for more than one day, OR if you are not sure for how long, YOU MAY BECOME PREGNANT. Start a new four-week cycle immediately by putting on a new patch. You now have a new Day 1 and a new “Patch Change Day”. You must use back-up contraception for the first week of your new cycle.
  • do not try to re-apply a patch if it is no longer sticky, if it has become stuck to itself or another surface, if it has other material stuck to it, or if it has become loose or has fallen off before. No tapes or wraps should be used to keep the patch in place. If you cannot re-apply a patch, apply a new patch immediately.

Overdose:

In case of suspected overdose, remove all patches and contact your doctor, hospital or regional Poison Control Centre, even if there are no symptoms.

Overdose may cause nausea and vomiting. Vaginal bleeding may occur in women.

If you forget to change your patch:

  • at the start of any patch cycle, Week one (Day 1): if you forget to apply your patch, you may become pregnant—you must use back-up contraception for one week. Apply the first patch of your new cycle as soon as you remember. You now have a new “Patch Change Day” and new Day 1. If you had sexual intercourse during this time, you may be at risk of pregnancy. Check with your doctor or clinic.
  • in the middle of your patch cycle, Week two or week three: if you forget to change your patch for one or two days, apply a new patch as soon as you remember. Apply your next patch on your normal “Patch Change Day”. No back-up contraception is needed.
  • Week two or week three: if you forget to change your patch for more than two days, you may become pregnant—start a new four-week cycle as soon as you remember by putting on a new patch. You now have a different “Patch Change Day” and a new Day 1. You must use back-up contraception for the first week of your new cycle.
  • at the end of your patch cycle, Week four: if you forget to remove your patch, take it off as soon as you remember. Start your next cycle on your normal “Patch Change Day”, the day after Day 28. No back-up contraception is needed.
  • at the start of your next patch cycle, Day 1 (Week one): if you forget to apply your patch, you may become pregnant—apply the first patch of your new cycle as soon as you remember. You now have a new “Patch Change Day” and new Day 1. You must use back-up contraception for the first week of your new cycle.
  • you should never have the patch off for more than seven days.

Other information:

  • Always apply your patch to clean, dry, hairless skin. Avoid skin that is red, irritated or cut. Do not use creams, oils, powder or makeup on your skin where you will put a patch or near a patch you are wearing. It may cause the patch to become loose.
  • Do not cut, damage or alter the patch in any way.
  • If patch use results in uncomfortable irritation, a new patch may be applied to a new location until the next change day. Only one patch should be worn at a time.
  • Some medicines may change the way the transdermal contraceptive system works. If you are taking any medication, you must talk to your health professional BEFORE you use the patch. You may need to use back-up contraception.

Disposal of EVRA:

Used patches still contain some active hormones. Throw away the used patch by carefully folding in half so the adhesive side sticks to itself, place the folded patch in a sturdy container, preferably with a child-resistant cap, and dispose of it in the garbage out of the reach of children and pets. Remaining active hormonal ingredients of the patch may have harmful effects if they reach the aquatic environment. Used patches should not be flushed down the toilet or placed in liquid waste disposal systems.

When you switch from the pill to EVRA:

If you are switching from the pill to EVRA, wait until you get your menstrual period. If you do not get your period within five days of taking the last active pill, check with your doctor or clinic before starting EVRA.

Important Points to Remember:

  1. It is important to use EVRA exactly as directed in this leaflet. Dosing errors increase your chances of becoming pregnant. This includes starting your contraceptive cycle late or missing your scheduled Change Day.
  2. Do not use EVRA for any condition other than the one for which it was prescribed. EVRA has been prescribed specifically for you; do not give it to others who may want birth control.
  3. You should wear one patch per week for three weeks, followed by one week off. You should never have the patch off for more than seven days in a row. If you have the patch off for more than seven days in a row and you have had sexual intercourse during this time, you may be at risk of pregnancy. Check with your doctor or clinic.
  4. If you are not sure what to do about dosing errors:
    • Use a back-up method of birth control any time you have sex.
    • Contact your health professional for instructions.
  5. Do not skip patches even if you do not have sex very often.
  6. Many women have spotting or light bleeding, breast tenderness or may feel sick to their stomach during the first three cycles. If these symptoms occur, do not stop using EVRA. The problem will usually go away. If it doesn't go away, check with your doctor or clinic.
  7. Mistakes in using your patches can also cause spotting or light bleeding.
  8. Unlike the pill, the amount of drug you get from the EVRA patch should not be affected by vomiting or diarrhea.
  9. If you want to move your “Patch Change Day” to a different day of the week, contact your doctor.
  10. Be sure to have ready at all times:
    • A non-hormonal birth control (such as condoms, foam or sponge) to use as a back-up in case of dosing errors.
  11. If you have trouble remembering to change your contraceptive patch, talk to your doctor or clinic about how to make patch-changing easier or about using another method of birth control.
  12. There is no need to stop taking the EVRA contraceptive patch for a rest period.

If you have any questions or are unsure about the information in this leaflet, call your doctor or clinic.

Missed Periods:

There may be times when you may not menstruate regularly during your patch-free week. If you have used EVRA correctly and miss one menstrual period, continue using EVRA for the next cycle, but be sure to inform your health professional before doing so. If you have not used EVRA as instructed and missed a menstrual period, or if you missed two consecutive menstrual periods, you may be pregnant. Check with your health professional immediately to determine whether you are pregnant. Stop using EVRA and use a non-hormonal method of birth control until you are sure you are not pregnant.

Pregnancy Due To Contraceptive Patch Failure:

The incidence of pregnancy from hormonal contraceptive failure is approximately one percent (i.e. one pregnancy per 100 women per year) if used correctly. The chance of becoming pregnant increases with incorrect use. If contraceptive patch failure occurs, the risk to the fetus is minimal.

Non-contraceptive Benefits of Hormonal Contraceptives:

Several health advantages have been linked to the use of hormonal contraceptives:

  • Reduction in the incidence of cancer of the uterus and ovaries.
  • Reduction in the likelihood of developing benign (non-cancerous) breast disease and ovarian cysts.
  • Less menstrual blood loss and more regular cycles. The risk of developing iron-deficiency anemia is thus reduced.
  • There may be a decrease in painful menstruation and premenstrual syndrome (PMS).
  • Acne, excessive hair growth and male hormone-related disorders may also be improved.
  • Ectopic (tubal) pregnancy may occur less frequently.
  • Acute pelvic inflammatory disease may occur less frequently.

Side Effects

The following side effects have been observed in studies of women taking EVRA:

Skin Irritation:

Skin irritation, redness or rash may occur at the site of application. If this occurs, a new patch may be applied to a new location until the next Change Day.

Vaginal Bleeding:

Unexpected vaginal bleeding or spotting usually disappears after the first few cycles of contraceptive patch use and is not usually a reason to stop using EVRA. If the bleeding persists for more than one cycle or lasts for more than a few days, talk to your doctor.

Other:

Very Common: breast discomfort, nausea, headache, painful menstrual periods.

Common (frequent): abdominal pain/discomfort, acne, allergy, back pain, bleeding between periods, breast enlargement, breast pain, bronchitis, coughing, diarrhea, dizziness, fatigue, fever, flatulence, flu-like symptoms, genital itching, heavier menstrual flow, inflammation, migraine, muscle pain, rash, runny or stuffy nose, sore throat, urinary tract infection, vaginal discharge, vaginal discomfort/infection, vomiting, weight gain.

Uncommon: blood clots in the lung.

The following additional symptoms have been reported in women taking hormonal contraceptives in general:

  • Abdominal cramps/bloating
  • Breast changes (tenderness, enlargement)
  • Change in appetite
  • Change in menstrual flow, spotting, amenorrhea (lack of menstrual period)
  • Change in skin pigmentation (can be permanent)
  • Depression
  • Difficulty wearing contact lenses
  • Excessive hair growth or loss of scalp hair
  • Fluid retention/swelling of the extremities
  • Increase in size of uterine fibroids (benign growths in the uterus/womb)
  • Jaundice (yellowing of the skin or eyes)
  • Nervousness
  • Weight change (increase or decrease)

Warnings and Precautions

Serious Warnings and Precautions

The results of a recent study indicate that women using the ORTHO EVRA contraceptive patch (the formulation of EVRA marketed in the United States) had an increased risk of blood clots in the legs and lungs compared to women using an oral contraceptive. A different study indicated no difference in the risk of blood clots in the legs and lungs in women using ORTHO EVRA compared to women using an oral contraceptive. Women who are obese are at particularly high risk of blood clots.

Cigarette smoking increases the risk of serious cardiovascular side effects (heart and blood vessel problems) from hormonal contraceptives. This risk increases with age and with the number of cigarettes smoked. For this reason, hormonal contraceptives, including EVRA, should not be used by women who are over 35 and smoke.

The contraceptive patch DOES NOT PROTECT against sexually transmitted infections (STIs), including HIV/AIDS.

For protection against STIs, it is advisable to use latex or polyurethane condoms IN COMBINATION WITH the contraceptive patch.

Updated Information on risk of blood clots:

There have now been several studies conducted that have assessed the risk of blood clots in the legs and lungs in women using ORTHO EVRA compared to women using oral contraceptives. These studies reported results ranging from no increase in risk of blood clots to an approximate doubling of risk of blood clots in women using ORTHO EVRA.

BEFORE you use EVRA talk to your doctor or pharmacist if you:

  • smoke
  • weigh more than 90 kg (198 lbs)
  • have a history of breast disease (e.g., breast lumps) or a family history of breast cancer
  • have high blood pressure
  • have high cholesterol
  • have diabetes
  • have heart or kidney disease
  • have a history of seizures/epilepsy
  • have a history of depression
  • have a history of liver disease or jaundice
  • wear contact lenses
  • have uterine fibroids (benign tumours of the uterus)
  • may be pregnant or are breast-feeding

You should also inform your doctor about a family history of blood clots, heart attacks or strokes.

While wearing EVRA you should not expose the patch area to sources of heat such as heating pads, electric blankets, heated waterbeds, heat lamps, saunas and hot tubs, intensive sunbathing, etc., as this may increase the drug's ability to go through the skin and therefore result in too much exposure to the estrogen in the patch. This may also occur if you develop a fever. Contact your doctor for advice if you develop a fever.

If you see a different doctor, inform him or her that you are using the EVRA contraceptive patch.

Tell your doctor if you are scheduled for any laboratory tests since certain blood tests may be affected by hormonal contraceptives.

Also tell your doctor if you are scheduled for MAJOR surgery. You should consult your doctor about stopping EVRA four weeks before surgery and not using the contraceptive patch for a time period after surgery or during bed rest.

EVRA should be used only under the supervision of a doctor, with regular follow-up to identify side effects associated with its use. Your visits may include a blood pressure check, a breast exam, an abdominal exam and a pelvic exam, including a Pap smear. Visit your doctor three months or sooner after the initial examination. Afterward, visit your doctor at least once a year. Use EVRA only on the advice of your doctor and carefully follow all directions given to you. You must use the contraceptive patch exactly as prescribed. Otherwise, you may become pregnant.

If you and your doctor decide that, for you, the benefits of the EVRA contraceptive patch outweigh the risks, you should be aware of the following:

The Risks of Using EVRA:

  1. Circulatory disorders (including blood clots in legs, lungs, heart, eyes or brain): There have been cases of heart attack, stroke and blood clots in the legs, lungs and eyes in women using EVRA. Blood clots are the most common serious side effects of hormonal contraceptives, including the contraceptive patch. The risk of developing blood clots is especially high during the first year a woman ever uses a hormonal contraceptive or restarts the same or a different hormonal contraceptive after a break of 4 weeks or more. Clots can occur in many parts of the body.
  2. Be alert for the following symptoms and signs of serious adverse effects. Call your doctor immediately if they occur:
    • sharp pain in the chest, coughing blood, or sudden shortness of breath. These symptoms could indicate a possible blood clot in the lung.
    • pain and/or swelling in the calf. These symptoms could indicate a possible blood clot in the leg.
    • crushing chest pain or heaviness. These symptoms could indicate a possible heart attack.
    • sudden severe or worsening headache or vomiting, dizziness or fainting, disturbances of vision or speech, or weakness or numbness in an arm or leg. These symptoms could indicate a possible stroke.
    • sudden partial or complete loss of vision. This symptom could indicate a blood clot in the eye.
  3. Any of these conditions can cause death or disability. Clots also occur rarely in the blood vessels of the eye, resulting in blindness or impaired vision, or in a blood vessel leading to an arm or leg, resulting in damage to or loss of a limb.
  4. Women who use hormonal contraceptives have a higher incidence of blood clots. The risk of clotting seems to increase with higher estrogen doses. It is important, therefore, to use as low a dosage of estrogen as possible.
  5. Breast cancer: The most significant risk factors for breast cancer are increasing age and a strong history of breast cancer in the family (mother or sister). Other established risk factors include obesity, never having children, and having your first full-term pregnancy at a late age.
  6. Some women who use hormonal contraceptives may be at increased risk of developing breast cancer before menopause, which occurs around age 50. These women may be long-term users of hormonal contraceptives (more than eight years) or women who start using hormonal contraceptives at an early age. In a few women, the use of hormonal contraceptives may accelerate the growth of an existing but undiagnosed breast cancer. Early diagnosis, however, can reduce the effect of breast cancer on a woman's life expectancy. The potential risks related to hormonal contraceptives seem to be small, however.
  7. A yearly breast examination by a health care professional is recommended for all women.
  8. ASK YOUR DOCTOR FOR ADVICE AND INSTRUCTIONS ON REGULAR SELF-EXAMINATION OF YOUR BREASTS.
  9. Cervical cancer: Some studies have found an increase of cancer of the cervix in women who use oral contraceptives, although this finding may be related to factors other than the use of oral contraceptives. However, there is insufficient evidence to rule out the possibility that oral contraceptives may cause such cancers.
  10. Liver tumours: The short- and long-term use of birth control pills also has been linked with the growth of liver tumours. Such tumours are extremely rare. Since the contraceptive patch contains hormones similar to those in birth control pills, this association may also exist with the contraceptive patch.
  11. Contact your doctor immediately if you experience severe pain or a lump in the abdomen.
  12. Gallbladder disease: Users of hormonal contraceptives, including the contraceptive patch, have a greater risk of developing gallbladder disease including inflammation and gallstones requiring surgery within the first year of use. The risk may double after four or five years of use.
  13. Seizures (convulsions): There have been rare cases of seizures (convulsions) in women using EVRA. It is important to contact your doctor immediately if you experience a new seizure or worsening of a previous seizure disorder (e.g. epilepsy).
  14. Body weight >90 kg (198 lbs): The effectiveness of EVRA may be reduced in women weighing more than 90 kg (198 lbs). If you weigh more than 90 kg (198 lbs) you should talk to your doctor to determine which method of birth control may be right for you.
  15. Use in pregnancy: Hormonal contraceptives, including the EVRA contraceptive patch, should not be taken if you think you are pregnant. They will not prevent the pregnancy from continuing. There is no evidence, however, that hormonal contraceptives can damage a developing child. You should check with your doctor about risks to your unborn child from any medication taken during pregnancy.
  16. Use after pregnancy, miscarriage or an abortion: Your doctor will advise you of the appropriate time to start the use of EVRA after childbirth, miscarriage, or therapeutic abortion.
  17. Pregnancy after stopping EVRA: You will have a menstrual period when you stop using EVRA. There may be some delay in becoming pregnant after you stop using the contraceptive patch, especially if you had irregular menstrual cycles before you used the contraceptive patch.
  18. There is no evidence that the use of hormonal contraceptives immediately before a pregnancy will adversely affect a baby's development. When a woman stops taking the contraceptive patch to become pregnant, however, her doctor may recommend a different form of contraception until she has a period on her own. In this way the pregnancy can be more accurately dated.
  19. Use while breast-feeding: If you are breast-feeding, consult your doctor before starting EVRA. Hormonal contraceptives are passed on to the child in the milk. A few adverse effects on the child have been reported, including yellowing of the skin (jaundice) and breast enlargement. In addition, combination hormonal contraceptives may decrease the amount and quality of your milk. If hormonal contraceptives are not resumed until nursing is established, however, the quantity and quality of breast milk does not seem to be affected. You should use a barrier method of contraception since breast-feeding only provides partial protection from becoming pregnant and this partial protection decreases significantly as you breast-feed for longer periods of time. It is recommended that you do not use combination hormonal contraceptives while breast-feeding. You should consider starting EVRA only after you have weaned your child completely.

Interactions with this medication

Tell your doctor or pharmacist if you are taking, or have been taking, any other medicines, even medicines you buy without a prescription, and herbal products. Certain drugs may interact with hormonal contraceptives, including EVRA, to make them less effective in preventing pregnancy or cause unexpected bleeding (spotting or breakthrough bleeding). EVRA may also interfere with how other drugs work. Talk to your doctor or pharmacist about when you may need to use an additional back-up, non-hormonal method of birth control (such as condoms, foam or sponge).

Drugs that may interact with EVRA include:

  • drugs used for epilepsy (e.g., carbamazepine, oxcarbazepine, ethosuximide, phenobarbital, phenytoin, primidone, rufinamide, topiramate, lamotrigine);
  • antibiotics (e.g., penicillins, metronidazole, cotrimoxazole, nitrofurantoin, sulfonamides);
  • drugs used for tuberculosis (e.g., rifampin, rifabutin);
  • (fos)aprepitant (drug used for nausea);
  • selegiline (drug used for Parkinson's disease);
  • tizanidine (drug used for multiple sclerosis [MS]);
  • Tetracycline has been shown not to interact with EVRA;
  • drugs used for HIV/AIDS (e.g., atazanavir, indinavir, nelfinavir, ritonavir, ritonavir-boosted protease inhibitors, etravirine, nevirapine);
  • cyclosporine;
  • antifungals (e.g., griseofulvin, itraconazole, ketoconazole, voriconazole, fluconazole);
  • salicylic acid;
  • anticoagulants (blood thinners);
  • the herbal remedy St. John's wort (pregnancies and breakthrough bleeding have been reported by users of combined oral contraceptives who also used St. John's wort);
  • blood pressure medications;
  • bronchodilators (drugs used for the treatment of asthma, chronic obstructive pulmonary disease, chronic bronchitis e.g., theophylline);
  • diabetic medications;
  • prednisone, prednisolone;
  • lipid-lowering drugs (e.g. atorvastatin, rosuvastatin);
  • sedatives (e.g. benzodiazepines, barbiturates, chloral hydrate, glutethimide, meprobamate);
  • stimulants (e.g. modafinil);
  • antacids;
  • acetaminophen;
  • bosentan (drug used for pulmonary hypertension which is high blood pressure in the blood vessels between the heart and the lungs);
  • grapefruit juice; and
  • some nutritional supplements (e.g., vitamin C, vitamin B12, folic acid).

This is not a complete list of possible drug interactions with EVRA. Talk to your doctor for more information about drug interactions.

Other related products

Eurax Cream (Crotamiton)

Author , posted on July 5, 2017

Category:


Eurax Cream

Crotamiton

Select Quantity:

Eurax (crotamiton)

EURAX is an anti-parasite medicine that kills certain parasites that live or lay eggs in your skin. EURAX topical (for the skin) is used to treat scabies and to reduce itching associated with certain skin conditions.

Proper Use of this medication

Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.

Do not take by mouth. EURAX topical is for use only on the skin. Do not use this medicine on swollen or oozing skin. If this medicine gets in your eyes or mouth, rinse with water.

Shake the lotion well just before each use.

To treat itching:

  • Massage the medicine into the affected areas until it is completely absorbed. Repeat as needed.

To treat scabies:

  • Take a bath or shower and dry your skin thoroughly before applying this medicine.
  • Apply a thin layer of the cream or lotion to all body parts from the neck down to the soles of your feet (scabies does not usually infect the head).
  • Be sure the medicine gets into all the folds of your skin, between your toes and fingers, and underneath your nails. Scabies are likely to stay under the nails if the area is not treated. Keep the nails trimmed short.
  • Leave the medicine on for 24 hours. Then apply a second dose without washing your skin first.
  • Thoroughly wash off the medicine 48 hours after the last application.

Call your doctor if you still have itching 2 to 4 weeks after you finish treatment for scabies.

To prevent reinfection, wash all clothing, hats, bed clothes, bed linens, hair brushes, and combs with a strong cleanser in hot water to remove any mites or eggs.

Store at room temperature away from moisture and heat.

An overdose of EURAX topical is not expected to be dangerous. Seek emergency medical attention or call the Poison Help line if anyone has accidentally swallowed the medication.

You will need to use both doses of EURAX topical, 24 hours apart. If you miss the second dose, you may need to start your treatment over.

Call your doctor for instructions if you miss a dose.

Side Effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using this medicine and call your doctor at once if you have:

  • severe burning, stinging, or irritation after using this medicine.

Common side effects may include:

  • mild itching or new rash.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Warnings and Precautions

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

You should not use this medicine if you have ever had an allergic reaction to a topical medication.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether EURAX topical passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

EURAX topical is not approved for use by anyone younger than 18 years old.

Interactions with this medication

Avoid getting this medicine in your eyes or mouth.

Parasite infestations are highly contagious. Using this medicine will not prevent you from passing scabies to other people. Avoid sexual or intimate contact until the infestation has cleared up. Also avoid sharing hair combs, hair accessories, hats, clothing, bed linens, and other articles of personal use.

It is not likely that other drugs you take orally or inject will have an effect on topically applied EURAX. But many drugs can interact with each other. Tell each of your health care providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.

Eulexin (Flutamide)

Author , posted on July 5, 2017

Category:


Flutamide (Generic)

Flutamide

Select Quantity:

Flutamide (Generic)

Flutamide

Select Quantity:

Flutamide (Generic)

Flutamide

Select Quantity:

Eulexin (Flutamide) Dosage and Side Effects

EULEXIN is an antiandrogen. It works in the body to prevent the actions of androgens (male hormones). EULEXIN is used together with another hormone to treat prostate cancer.

Proper Use of this medication

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

EULEXIN is usually taken every 8 hours. Follow your doctor's instructions.

Call your doctor if you have severe or ongoing diarrhea. Your doctor may recommend an anti-diarrhea medicine.

Drink plenty of liquids while you are taking EULEXIN. Your doctor may recommend a special diet to help prevent diarrhea.

While using EULEXIN, you may need frequent blood tests.

EULEXIN is given as part of a combination prostate cancer treatment with another medicine called a luteinizing (LOO-tee-in-ize-ing) hormone-releasing hormone, or LHRH. These medicines prevent the testicles from producing testosterone.

You should not stop using EULEXIN suddenly. Stopping suddenly may make your condition worse.

Store at room temperature away from moisture, heat, and light.

Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.

Seek emergency medical attention or call the Poison Help line.

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Call your doctor for instructions if you miss an appointment for your LHRH injection.

Side Effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

EULEXIN can cause serious liver problems. Call your doctor at once if you have:

  • nausea, upper stomach pain, loss of appetite;
  • itching, tired feeling, flu-like symptoms;
  • dark urine, clay-colored stools; or
  • jaundice (yellowing of the skin or eyes).

Common side effects may include:

  • breast swelling or tenderness;
  • hot flashes;
  • vomiting, diarrhea; or
  • impotence, loss of interest in sex.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Warnings and Precautions

EULEXIN can cause serious liver problems. Call your doctor at once if you have upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).

You will need frequent blood tests to check your liver function while you are taking EULEXIN .

You should not use this medicine if you are allergic to EULEXIN.

EULEXIN should never be taken by a woman or a child.

Although EULEXIN is not for use by women, this medicine can cause birth defects if a woman is exposed to it during pregnancy.

To make sure EULEXIN is safe for you, tell your doctor if you have:

  • liver disease;
  • a genetic enzyme deficiency called glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • hemoglobin M disease;
  • if you smoke; or
  • if you also take a blood thinner (warfarin, Coumadin, Jantoven).

Interactions with this medication

To help prevent diarrhea, avoid dairy products such as milk, cheese, and yogurt. Do not use laxatives while taking EULEXIN.

This medicine can pass into body fluids (urine, feces, vomit). Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.

Other drugs may interact with EULEXIN, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Other related products

Euflexxa (Hyaluronate Sodium)

Author , posted on July 5, 2017

Category:


Euflexxa

Hyaluronate Sodium

Select Quantity:

Euflexxa (Hyaluronate Sodium) Dosage and Side Effects

EUFLEXXA is similar to the fluid that surrounds the joints in your body. This fluid acts as a lubricant and shock absorber for the joints. EUFLEXXA is used to treat knee pain caused by osteoarthritis. EUFLEXXA is usually given after other arthritis medications have been tried without successful treatment of symptoms.

Proper Use of this medication

EUFLEXXA is injected directly into your knee joint. A healthcare provider will give you this injection.

EUFLEXXA is usually given once every week for 3 to 5 weeks. Follow your doctor's dosing instructions very carefully.

To prevent pain and swelling, your doctor may recommend resting your knee or applying ice for a short time after your injection.

Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

Call your doctor for instructions if you miss an appointment for your EUFLEXXA injection.

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • severe pain or swelling around the knee after the injection;
  • fast heart rate, sweating, chills or shaking; or
  • heavy feeling, anxiety, confusion.

Less serious side effects may include:

  • warmth, pain, stiffness, swelling, or puffiness where the medicine was injected;
  • nausea, stomach pain;
  • headache;
  • back pain;
  • numbness or tingly feeling;
  • cold symptoms such as stuffy nose, sneezing, sore throat;
  • tired feeling; or
  • itching or skin irritation around the knee.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Warnings and Precautions

You should not receive EUFLEXXA if you are allergic to it, or if you have an infection in your knee or in the skin around your knee.

Before you receive a EUFLEXXA injection, tell your doctor if you have blood clots or circulation problems in your legs, or an allergy to birds, feathers, or egg products.

For at least 48 hours after your injection, avoid jogging, strenuous activity, high-impact sports, or standing for longer than 1 hour at a time.

Call your doctor at once if you have severe pain or swelling around the knee after the injection.

You should not receive EUFLEXXA if you are allergic to it, or if you have an infection in your knee or in the skin around your knee.

To make sure you can safely receive EUFLEXXA, tell your doctor if you have:

  • blood clots or circulation problems in your legs; or
  • an allergy to birds, feathers, or egg products.

It is not known whether EUFLEXXA will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether EUFLEXXA passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Interactions with this medication

For at least 48 hours after your injection, avoid jogging, strenuous activity, or high-impact sports such as soccer or tennis. Also avoid weight-bearing activity or standing for longer than 1 hour at a time. Ask your doctor how long to wait before you resume these activities.

There may be other drugs that can interact with EUFLEXXA. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Other related products

Myambutol (Ethambutol)

Author , posted on July 5, 2017

Category:


Etibi

Ethambutol

Select Quantity:
Select Quantity:

Ethambutol (Generic)

Ethambutol

Select Quantity:

Myambutol (Ethambutol) Dosage and Side Effects

MYAMBUTOL is an antibiotic that prevents growth of the tuberculous bacteria in the body. MYAMBUTOL is used to treat tuberculosis (TB), and is usually given together with at least one other tuberculosis medicine.

Proper Use of this medication

Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Tell your doctor if you have ever used tuberculosis medicine before. Your dose may be different if you have been treated for tuberculosis in the past.

You may take MYAMBUTOL with or without food.

MYAMBUTOL may be taken with food if it upsets your stomach.

Tell your doctor if you have any changes in weight. MYAMBUTOL doses are based on weight and your dose may also need to be changed.

Your vision will need to be checked often while you are taking MYAMBUTOL. If you wear glasses, take them with you to your vision examination.

Your blood cells, kidney function, and liver function may also need to be checked.

Use this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. MYAMBUTOL will not treat a viral infection such as the flu or a common cold.

Tuberculosis is sometimes treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice.

Store at room temperature away from moisture and heat.

Seek emergency medical attention or call the Poison Help line.

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

MYAMBUTOL can cause serious vision problems, including vision loss that may be permanent. Stop using MYAMBUTOL and call your doctor at once if you have any problems with one or both of your eyes, such as:

  • blurred vision or trouble focusing;
  • loss of vision in one eye that lasts an hour or longer;
  • increased sensitivity of your eyes to light;
  • loss of color vision; or
  • pain with eye movement, pain behind your eyes.

Call your doctor at once if you have:

  • new or worsening cough with fever, trouble breathing;
  • numbness of tingling in your hands or feet;
  • confusion, hallucinations;
  • fever, swollen glands, painful mouth sores, skin sores, cold or flu symptoms, general ill feeling;
  • easy bruising or bleeding (nosebleeds, bleeding gums);
  • chest pain or shortness of breath with mild exertion;
  • little or no urinating;
  • liver problems--upper stomach pain, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
  • severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Common side effects may include:

  • itching or rash;
  • joint pain;
  • headache, dizziness; or
  • nausea, vomiting, stomach pain, indigestion, loss of appetite.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

 

Warnings and Precautions

MYAMBUTOL can cause serious vision problems or irreversible vision loss. You may not be able to take this medicine if you have an eye problem or vision disorder.

You should not use MYAMBUTOL if you are allergic to it. You may not be able to take MYAMBUTOL if you have an eye condition called optic neuritis (inflammation of nerve fibers behind your eyes). Your doctor will decide if this treatment is right for if you have an eye disorder.

MYAMBUTOL can cause vision problems that may be a sign that you should stop taking the medicine. You may not be able to take MYAMBUTOL if you cannot recognize or report any changes in your vision. Young children or debilitated patients may not be able to tell someone about vision problems.

To make sure MYAMBUTOL is safe for you, tell your doctor if you have:

  • inflammatory eye disorders such as uveitis or iritis;
  • eye problems caused by diabetes;
  • cataracts;
  • liver disease;
  • kidney disease; or
  • gout.

FDA pregnancy category C. It is not known whether MYAMBUTOL will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

MYAMBUTOL can pass into breast milk and may harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

MYAMBUTOL should not be given to a child younger than 13 years old.

Interactions with this medication

Avoid taking an antacid containing aluminum hydroxide (Alternagel, Maalox, Mi-Acid, Mylanta, Rulox) within 4 hours after you take MYAMBUTOL. Some antacids can make it harder for your body to absorb MYAMBUTOL.

Other drugs may interact with MYAMBUTOL, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.